Maxim Group Downgrades Biotricity to Hold
Maxim Group analyst Allen Klee downgrades Biotricity (NASDAQ:BTCY) from Buy to Hold.
HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2
HC Wainwright & Co. analyst Kevin Dede maintains Biotricity (NASDAQ:BTCY) with a Buy and lowers the price target from $6 to $2.
InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
37 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
77 Biggest Movers From Yesterday
Gainers
TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.